For people with non-valvular atrial fibrillation rivaroxaban is non-inferior to warfarin for preventing stroke or embolism, with no difference in the risk of clinically relevant bleeding.

Link to article at PubMed

For people with non-valvular atrial fibrillation rivaroxaban is non-inferior to warfarin for preventing stroke or embolism, with no difference in the risk of clinically relevant bleeding.

Evid Based Med. 2012 Feb 18;

Authors: Sherwood M, Piccini JP

PMID: 22345038 [PubMed - as supplied by publisher]

Leave a Reply

Your email address will not be published.